Systemic immunotoxin therapy of cancer: advances and prospects.
Wawrzynczak
E J
EJ
Drug Targeting Laboratory, Institute of Cancer Research, Sutton, Surrey, UK.
D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000627:therapeutic use; D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000276:immunology; D002986:Clinical Trials as Topic; D004339:Drug Compounding; D000922:Immunotoxins / Q000009:adverse effects / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D012276:Ricin / Q000737:chemistry / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000922:Immunotoxins; D012276:Ricin